BSC has launched a new spin-off, ELEM Biotech, which will allow companies of medical technologies, pharmaceuticals, CROs and doctors to perform virtual simulations for the personalized treatment of some diseases.
UK doctors think Britain’s exit from the European Union will be very bad for the NHS, reveal the results of a study from UCL, the London School of Hygiene & Tropical Medicine (LSHTM) and Queen Mary University of London.
The Estonian genome project will provide personal feedback on the genetic information of a third of the population, laying the foundations for personalised medicine
At the Euroscience Open Forum conference, a Bulgarian medical start-up demonstrates the potential - and the challenges - of getting health systems to focus on preventing disease, rather than responding when it strikes
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.